ask="1.3200"
ask_size="1000"
average_daily_volume="105498"
bid="0.6700"
bid_size="800"
book_value="0.5310"
change="+0.0002"
change_from_200_day_moving_average="-0.4709"
change_from_50_day_moving_average="-0.2549"
change_from_52_week_high="-7.0198"
change_From_52_week_low="0.0302"
change_in_percent="+0.0215%"
close="0.9302"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.0100"
ebitda="-15.83M"
eps_estimate_current_year="-0.8200"
eps_estimate_next_quarter="-0.2200"
eps_estimate_next_year="-0.7300"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.9480"
high_52_weeks="7.9500"
last_trade_date="3/8/2017"
last_trade_price="0.9302"
last_trade_size="225"
last_trade_time="3:47pm"
low="0.9000"
low_52_weeks="0.9000"
market_capitalization="15.25M"
moving_average_200_day="1.4011"
moving_average_50_day="1.1851"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="0.9201"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-33.6103%"
percent_change_from_50_day_moving_average="-21.5081%"
percent_change_from_52_week_high="-88.2994%"
percent_change_from_52_week_low="+3.3556%"
previous_close="0.9300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7514"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.2300"
stock_exchange="NGM"
symbol="ORPN"
volume="38019"
weeks_range_52="0.9000 - 7.9500"
